Get started
TAIKO PHARMACEUTICAL CO LTDTAIKO PHARMACEUTICAL CO LTDTAIKO PHARMACEUTICAL CO LTD

TAIKO PHARMACEUTICAL CO LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

4574 chart


Full chart

4574 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.08 B‬ JPY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−47 JPY
Net income (FY)
‪−3.61 B‬ JPY
Revenue (FY)
‪6.12 B‬ JPY
Shares float
‪28.41 M‬
Beta (1Y)
0.85

Employees


Employees (FY)
208
Change (1Y)
−2 −0.95%
Revenue / Employee (1Y)
‪29.42 M‬ JPY
Net income / Employee (1Y)
‪−17.36 M‬ JPY

About TAIKO PHARMACEUTICAL CO LTD


Sector
Health Technology
Headquarters
Osaka
Founded
1940
Website
seirogan.co.jp
ISIN
JP3442200006
FIGI
BBG000DPW4Z7
Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the sale of gastrointestinal drugs such as Seirogan, Seirogan Toui A, and Seirogan Quick C. The Infection Control segment offers hygiene products such as Cleverin and clev&and. The Others segment provides vinegar-related products. The company was founded by Otojiro Shibata in July 1940 and is headquartered in Osaka, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4574 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4574 is 323 JPY — it has increased by 0.62% in the past 24 hours. Watch TAIKO PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TAIKO PHARMACEUTICAL CO LTD stocks are traded under the ticker 4574.
4574 stock has risen by 0.94% compared to the previous week, the month change is a −12.70% fall, over the last year TAIKO PHARMACEUTICAL CO LTD has showed a 19.63% increase.
4574 reached its all-time high on Aug 20, 2020 with the price of 2,928 JPY, and its all-time low was 197 JPY and was reached on May 31, 2012. View more price dynamics on 4574 chart.
See other stocks reaching their highest and lowest prices.
4574 stock is 2.19% volatile and has beta coefficient of 0.85. Track TAIKO PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is TAIKO PHARMACEUTICAL CO LTD there?
Today TAIKO PHARMACEUTICAL CO LTD has the market capitalization of ‪16.11 B‬, it has increased by 0.31% over the last week.
Yes, you can track TAIKO PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
TAIKO PHARMACEUTICAL CO LTD is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
4574 net income for the last quarter is ‪−50.00 M‬ JPY, while the quarter before that showed ‪292.00 M‬ JPY of net income which accounts for −117.12% change. Track more TAIKO PHARMACEUTICAL CO LTD financial stats to get the full picture.
As of Dec 26, 2024, the company has 208.00 employees. See our rating of the largest employees — is TAIKO PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAIKO PHARMACEUTICAL CO LTD EBITDA is ‪532.00 M‬ JPY, and current EBITDA margin is −4.93%. See more stats in TAIKO PHARMACEUTICAL CO LTD financial statements.
Like other stocks, 4574 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAIKO PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAIKO PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAIKO PHARMACEUTICAL CO LTD stock shows the strong sell signal. See more of TAIKO PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.